FNDC8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.572200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.686400E-01
Normal-vs-Stage2
7.562800E-01
Normal-vs-Stage3
6.538400E-01
Normal-vs-Stage4
5.812400E-01
Stage1-vs-Stage2
5.122400E-01
Stage1-vs-Stage3
5.125200E-01
Stage1-vs-Stage4
1.355640E-01
Stage2-vs-Stage3
7.862200E-01
Stage2-vs-Stage4
3.185600E-01
Stage3-vs-Stage4
5.657600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.738000E-01
Normal-vs-AfricanAmerican
9.318400E-01
Normal-vs-Asian
4.964800E-01
Caucasian-vs-AfricanAmerican
3.523600E-01
Caucasian-vs-Asian
6.738900E-03
AfricanAmerican-vs-Asian
1.028210E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.043400E-01
Normal-vs-Female
8.251600E-01
Male-vs-Female
3.824000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.623800E-01
Normal-vs-Age(41-60Yrs)
8.393200E-01
Normal-vs-Age(61-80Yrs)
7.212200E-01
Normal-vs-Age(81-100Yrs)
6.929000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.271600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.245200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.898000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.964300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.508600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.692400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.744200E-01
Normal-vs-Daily Drinker
6.204800E-01
Normal-vs-Weekly Drinker
7.610000E-01
Normal-vs-Occasional Drinker
7.722000E-01
Normal-vs-Social Drinker
9.720200E-01
Non Drinker-vs-Daily Drinker
5.044000E-01
Non Drinker-vs-Weekly Drinker
4.196800E-01
Non Drinker-vs-Occasional Drinker
3.524400E-01
Non Drinker-vs-Social Drinker
4.184000E-02
Daily Drinker-vs-Weekly Drinker
2.379800E-01
Daily Drinker-vs-Occasional Drinker
1.947810E-01
Daily Drinker-vs-Social Drinker
1.299760E-02
Weekly Drinker-vs-Occasional Drinker
9.377000E-01
Weekly Drinker-vs-Social Drinker
2.187400E-01
Occasional Drinker-vs-Social Drinker
2.293800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.312800E-01
Normal-vs-Grade 2
8.541600E-01
Normal-vs-Grade 3
9.184600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.318000E-01
Grade 1-vs-Grade 3
8.286200E-01
Grade 1-vs-Grade 4
8.312800E-01
Grade 2-vs-Grade 3
2.501800E-01
Grade 2-vs-Grade 4
8.541600E-01
Grade 3-vs-Grade 4
9.184600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.585000E-01
Normal-vs-NonDiabetic
7.546600E-01
Diabetic-vs-NonDiabetic
1.527790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.075600E-01
Normal-vs-NoPancreatitis
7.121000E-01
Pancreatitis-vs-NoPancreatitis
1.363220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.764800E-01
Normal-vs-N1
7.584200E-01
N0-vs-N1
8.108400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.368400E-01
Normal-vs-TP53-NonMutant
7.937000E-01
TP53-Mutant-vs-TP53-NonMutant
5.095600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
